Karin S. Blanchard

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard et al. · Nature Biotechnology · 2005 · 1.2K citations

Medicinal Chemistry, Viral Hepatitis, Immunology +9

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†

Karin S. Blanchard, Lucinda Shaw, Kristi Jensen et al. · Hepatology · 2005 · 290 citations · Full text

Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.

P A Pavco, Karyn Bouhana, Adalberto M. Gallegos et al. · PubMed · 2000 · 160 citations

Messenger Rna, Tumor Biology, Angiogenesis +16

Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME) in healthy volunteers.

Jennifer A. Sandberg, Vann P. Parker, Karin S. Blanchard et al. · PubMed · 2000 · 51 citations

Ribozyme Administration, Pharmacological Study, Clinical Therapeutic +11

Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice

Patrice A. Lee, Lawrence M. Blatt, Karin S. Blanchard et al. · Hepatology · 2000 · 49 citations